Equillium, Inc. (EQ)
1.27
-0.15
(-10.56%)
USD |
NASDAQ |
Oct 22, 16:00
1.26
-0.01
(-0.79%)
After-Hours: 20:00
Equillium Shareholders Equity (Quarterly) : 56.02M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 56.02M |
| March 31, 2026 | 59.49M |
| December 31, 2025 | 28.60M |
| September 30, 2025 | 30.94M |
| June 30, 2025 | 5.056M |
| March 31, 2025 | 10.58M |
| December 31, 2024 | 19.06M |
| September 30, 2024 | 23.18M |
| June 30, 2024 | 22.43M |
| March 31, 2024 | 21.09M |
| December 31, 2023 | 22.57M |
| September 30, 2023 | 24.11M |
| June 30, 2023 | 26.98M |
| March 31, 2023 | 29.27M |
| December 31, 2022 | 31.94M |
| September 30, 2022 | 28.16M |
| Date | Value |
|---|---|
| June 30, 2022 | 40.27M |
| March 31, 2022 | 52.63M |
| December 31, 2021 | 66.50M |
| September 30, 2021 | 75.80M |
| June 30, 2021 | 84.77M |
| March 31, 2021 | 91.88M |
| December 31, 2020 | 69.85M |
| September 30, 2020 | 78.13M |
| June 30, 2020 | 30.97M |
| March 31, 2020 | 36.35M |
| December 31, 2019 | 41.85M |
| September 30, 2019 | 48.96M |
| June 30, 2019 | 54.06M |
| March 31, 2019 | 59.49M |
| December 31, 2018 | 64.94M |
| September 30, 2018 | -10.38M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 58.67M |
| Total Liabilities (Quarterly) | 2.65M |
| Debt to Equity Ratio | 0.0104 |
| Current Ratio | 23.40 |
| Net Debt Paydown Yield | -0.03% |